• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用高分辨率熔解分析快速检测核心结合因子急性髓系白血病中的KIT突变

Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.

作者信息

Fuster Oscar, Barragán Eva, Bolufer Pascual, Cervera José, Larráyoz Maria José, Jiménez-Velasco Antonio, Martínez-López Joaquín, Valencia Ana, Moscardó Federico, Sanz Miguel Angel

机构信息

Laboratory of Molecular Biology, Department of Medical Pathology, Escuela de enfermería 7 planta. Hospital Universitario La Fe, Avd. Campanar 21, Valencia 46009, Spain.

出版信息

J Mol Diagn. 2009 Sep;11(5):458-63. doi: 10.2353/jmoldx.2009.090043. Epub 2009 Jul 30.

DOI:10.2353/jmoldx.2009.090043
PMID:19644024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2729844/
Abstract

The most frequent KIT mutations reported in core-binding factor acute myeloid leukemia are point mutations and insertions/deletions in exons 17 and 8. The vast majority of KIT mutation detection procedures are time-consuming, costly, or with a high lower limit of detection. High-resolution melting (HRM) is a gene scanning method that combines simplicity and rapid identification of genetic variants. We describe an HRM method for the simultaneous screening of exons 8 and 17 KIT mutations and report the results obtained in 69 core-binding factor acute myeloid leukemia patients. Mutation detection was compared with sequencing as the gold standard. The HRM method used high-resolution melting master reagents (Roche) and the LightCycler 480 (Roche) platform. HRM was reproducible, showed a lower limit of detection of 1%, and discriminated all patients with mutated KIT from controls without false positive or false negative results. Additionally, most of the mutations were differentiated from the other mutations. KIT mutations were present in 15.9% of patients, showing a higher incidence in inv(16) (25.8%) than in t(8;21) (7.9%). The presence of a KIT mutation was associated with a high white blood cell count, and adult patients with an exon 17 mutation had a higher incidence of relapse. These findings verify that HRM is a reliable, rapid, and sensitive method for KIT mutation screening. Furthermore, our study corroborates the unfavorable prognosis associated with exon 17 KIT mutations.

摘要

在核心结合因子急性髓系白血病中报告的最常见的KIT突变是外显子17和8中的点突变以及插入/缺失。绝大多数KIT突变检测程序耗时、成本高或检测下限高。高分辨率熔解(HRM)是一种结合了简单性和快速识别基因变异的基因扫描方法。我们描述了一种用于同时筛查KIT基因外显子8和17突变的HRM方法,并报告了在69例核心结合因子急性髓系白血病患者中获得的结果。将突变检测与作为金标准的测序进行了比较。HRM方法使用高分辨率熔解主试剂(罗氏)和LightCycler 480(罗氏)平台。HRM具有可重复性,检测下限为1%,能将所有KIT突变患者与对照组区分开来,无假阳性或假阴性结果。此外,大多数突变与其他突变相区分。15.9%的患者存在KIT突变,inv(16)患者中的发生率(25.8%)高于t(

相似文献

1
Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.利用高分辨率熔解分析快速检测核心结合因子急性髓系白血病中的KIT突变
J Mol Diagn. 2009 Sep;11(5):458-63. doi: 10.2353/jmoldx.2009.090043. Epub 2009 Jul 30.
2
[Scanning of c-kit gene mutations in acute myeloid leukemias using high-resolution melting analysis].[利用高分辨率熔解分析检测急性髓系白血病中的c-kit基因突变]
Zhonghua Xue Ye Xue Za Zhi. 2011 Jan;32(1):21-4.
3
Core binding factor acute myeloid leukaemia and c-KIT mutations.核心结合因子急性髓系白血病和 c-KIT 突变。
Oncol Rep. 2013 May;29(5):1867-72. doi: 10.3892/or.2013.2328. Epub 2013 Mar 5.
4
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.核心结合因子急性髓系白血病的全面突变谱分析
Blood. 2016 May 19;127(20):2451-9. doi: 10.1182/blood-2015-12-688705. Epub 2016 Mar 15.
5
Comparison of high-resolution melting analysis with direct sequencing for the detection of recurrent mutations in DNA methyltransferase 3A and isocitrate dehydrogenase 1 and 2 genes in acute myeloid leukemia patients.高分辨率熔解分析与直接测序用于检测急性髓系白血病患者DNA甲基转移酶3A及异柠檬酸脱氢酶1和2基因复发性突变的比较
Eur J Haematol. 2016 Feb;96(2):181-7. doi: 10.1111/ejh.12566. Epub 2015 May 13.
6
Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia.在核心结合因子急性髓系白血病中,KIT外显子17突变的意义取决于突变水平而非阳性情况。
Blood Cancer J. 2016 Jan 15;6(1):e387. doi: 10.1038/bcj.2015.116.
7
Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia.采用液滴数字PCR监测核心结合因子急性髓系白血病患者中C-KIT基因第17外显子双突变的克隆演变
Leuk Res. 2018 Jun;69:89-93. doi: 10.1016/j.leukres.2018.04.013. Epub 2018 Apr 22.
8
KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia.KIT突变与核心结合因子急性髓系白血病患儿的不良生存相关。
Leuk Lymphoma. 2018 Apr;59(4):829-836. doi: 10.1080/10428194.2017.1361025. Epub 2017 Aug 9.
9
Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia.核心结合因子急性髓系白血病中 c-KIT 突变的预后影响。
Leuk Res. 2011 Oct;35(10):1376-83. doi: 10.1016/j.leukres.2011.06.003. Epub 2011 Jun 28.
10
[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].[核心结合因子相关急性髓系白血病酪氨酸激酶基因突变分析及其临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83.

引用本文的文献

1
A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia.一种针对急性髓系白血病中KIT突变的肽疫苗设计
Pharmaceuticals (Basel). 2023 Jun 27;16(7):932. doi: 10.3390/ph16070932.
2
Detection of KIT mutations in core binding factor acute myeloid leukemia.核心结合因子急性髓系白血病中KIT突变的检测
Leuk Res Rep. 2018 Jul 21;10:20-25. doi: 10.1016/j.lrr.2018.06.004. eCollection 2018.
3
Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis.高分辨率熔解分析检测KRAS突变的诊断准确性:一项系统评价和荟萃分析
Sci Rep. 2014 Dec 17;4:7521. doi: 10.1038/srep07521.
4
High-resolution melting curve analysis, a rapid and affordable method for mutation analysis in childhood acute myeloid leukemia.高分辨率熔解曲线分析,一种用于儿童急性髓细胞白血病突变分析的快速且经济实惠的方法。
Front Pediatr. 2014 Sep 9;2:96. doi: 10.3389/fped.2014.00096. eCollection 2014.
5
High resolution melting analysis: a rapid and accurate method to detect CALR mutations.高分辨率熔解分析:一种检测CALR突变的快速准确方法。
PLoS One. 2014 Jul 28;9(7):e103511. doi: 10.1371/journal.pone.0103511. eCollection 2014.
6
A novel melting curve-based method for detecting mutations in acute myeloid leukemia.一种基于熔解曲线的新型急性髓系白血病突变检测方法。
Oncol Lett. 2014 Jul;8(1):99-104. doi: 10.3892/ol.2014.2128. Epub 2014 May 9.
7
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del).一组以前被认为是野生型肿瘤的胃肠道间质瘤携带 KIT 外显子 8 中的体细胞激活突变(p.D419del)。
Mod Pathol. 2013 Jul;26(7):1004-12. doi: 10.1038/modpathol.2013.47. Epub 2013 Apr 19.
8
Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta analysis.高分辨率熔解曲线分析(HRMA)是否可准确检测与人类疾病相关的突变?一项荟萃分析。
PLoS One. 2011;6(12):e28078. doi: 10.1371/journal.pone.0028078. Epub 2011 Dec 14.
9
Mutation analysis of SLC26A4 for Pendred syndrome and nonsyndromic hearing loss by high-resolution melting.应用高分辨率熔解技术对 Pendred 综合征和非综合征性听力损失进行 SLC26A4 基因突变分析。
J Mol Diagn. 2011 Jul;13(4):416-26. doi: 10.1016/j.jmoldx.2011.03.003. Epub 2011 Apr 29.
10
Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis.高分辨率熔解曲线分析技术对罕见变异敏感的方法用于检测耐药性大流行 2009(H1N1)流感 A 病毒的超灵敏检测
J Clin Microbiol. 2011 Jul;49(7):2602-9. doi: 10.1128/JCM.00277-11. Epub 2011 May 4.

本文引用的文献

1
High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.JAK2基因第14外显子和第12外显子突变的高分辨率熔解分析:一种骨髓增殖性肿瘤的诊断工具。
J Mol Diagn. 2009 Mar;11(2):155-61. doi: 10.2353/jmoldx.2009.080110.
2
Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.使用高分辨率熔解分析快速鉴定JAK2外显子12突变
Haematologica. 2008 Oct;93(10):1560-4. doi: 10.3324/haematol.12883. Epub 2008 Aug 12.
3
Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.伴有t(8;21)(q22;q22)的急性髓系白血病:一种异质性疾病,在一部分患者中预后较差,与继发性细胞遗传学异常无关。
Mod Pathol. 2008 Aug;21(8):1029-36. doi: 10.1038/modpathol.2008.92. Epub 2008 Jun 6.
4
Cooperating gene mutations in acute myeloid leukemia: a review of the literature.急性髓系白血病中的协同基因突变:文献综述
Leukemia. 2008 May;22(5):915-31. doi: 10.1038/leu.2008.19. Epub 2008 Feb 21.
5
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.初发急性髓系白血病患者表达的酪氨酸激酶基因中的体细胞突变和种系序列变异
Blood. 2008 May 1;111(9):4797-808. doi: 10.1182/blood-2007-09-113027. Epub 2008 Feb 12.
6
Rapid and sensitive typing of NPM1 mutations using LNA-mediated PCR clamping.使用锁核酸(LNA)介导的PCR钳夹技术对NPM1突变进行快速灵敏的分型
Leukemia. 2006 Oct;20(10):1897-9. doi: 10.1038/sj.leu.2404367. Epub 2006 Sep 7.
7
A new D816 c-KIT gene mutation in refractory AML1-ETO leukemia.难治性AML1-ETO白血病中的一种新的D816 c-KIT基因突变。
Haematologica. 2006 Sep;91(9):1283-4.
8
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.KIT突变在伴inv(16)和t(8;21)的成人急性髓系白血病中的不良预后意义:癌症与白血病B组研究
J Clin Oncol. 2006 Aug 20;24(24):3904-11. doi: 10.1200/JCO.2006.06.9500.
9
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).核心结合因子急性髓系白血病(CBF-AML)中c-Kit、FLT3和Ras基因突变的发生率及预后影响
Leukemia. 2006 Jun;20(6):965-70. doi: 10.1038/sj.leu.2404188.
10
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.c-KIT突变在核心结合因子白血病中的预后影响:一项意大利回顾性研究。
Blood. 2006 May 1;107(9):3463-8. doi: 10.1182/blood-2005-09-3640. Epub 2005 Dec 29.